HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy-Reference-Cited by-同舟云学术

HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy

Published:2018-03-27 Issue:6 Volume:32 Page:715-720
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Logerot Sandrine,Rancez Magali,Charmeteau-de Muylder Bénédicte,Figueiredo-Morgado Suzanne,Rozlan Sandra,Tambussi Giuseppe,Beq Stéphanie,Couëdel-Courteille Anne,Cheynier Rémi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options;Gazzola;Clin Infect Dis,2009

2. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy;Mavigner;PLoS One,2009

3. Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection;Dion;Blood,2007

4. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy;Delobel;J Virol,2006

5. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution;Gaardbo;J Acquir Immune Defic Syndr,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the use of generalized dynamic weighted ordinary least squares for individualized HIV treatment strategies;The Annals of Applied Statistics;2023-09-01

2. Recent advances in poor HIV immune reconstitution: what will the future look like?;Frontiers in Microbiology;2023-08-07

3. Immunological mechanisms involved in the persistence of HIV reservoirs;Virologie;2022-01-01

4. Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence;Biochemical Pharmacology;2021-12

5. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment;Clinical Immunology;2021-08